PMV PHARMACEUTICALS INC (PMVP) Stock Fundamental Analysis

NASDAQ:PMVP • US69353Y1038

1.12 USD
+0.06 (+5.66%)
At close: Feb 25, 2026
1.15 USD
+0.03 (+2.68%)
After Hours: 2/25/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall PMVP gets a fundamental rating of 2 out of 10. We evaluated PMVP against 521 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for PMVP as it has an excellent financial health rating, but there are worries on the profitability. PMVP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year PMVP has reported negative net income.
  • PMVP had a negative operating cash flow in the past year.
  • In the past 5 years PMVP always reported negative net income.
  • In the past 5 years PMVP always reported negative operating cash flow.
PMVP Yearly Net Income VS EBIT VS OCF VS FCFPMVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • PMVP has a Return On Assets (-61.79%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -68.35%, PMVP is in line with its industry, outperforming 56.62% of the companies in the same industry.
Industry RankSector Rank
ROA -61.79%
ROE -68.35%
ROIC N/A
ROA(3y)-28.39%
ROA(5y)-22.41%
ROE(3y)-31.23%
ROE(5y)-24.41%
ROIC(3y)N/A
ROIC(5y)N/A
PMVP Yearly ROA, ROE, ROICPMVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PMVP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMVP Yearly Profit, Operating, Gross MarginsPMVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, PMVP has more shares outstanding
  • PMVP has more shares outstanding than it did 5 years ago.
  • PMVP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PMVP Yearly Shares OutstandingPMVP Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PMVP Yearly Total Debt VS Total AssetsPMVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • PMVP has an Altman-Z score of -2.89. This is a bad value and indicates that PMVP is not financially healthy and even has some risk of bankruptcy.
  • PMVP has a Altman-Z score of -2.89. This is comparable to the rest of the industry: PMVP outperforms 46.83% of its industry peers.
  • There is no outstanding debt for PMVP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.89
ROIC/WACCN/A
WACCN/A
PMVP Yearly LT Debt VS Equity VS FCFPMVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • PMVP has a Current Ratio of 10.76. This indicates that PMVP is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PMVP (10.76) is better than 84.84% of its industry peers.
  • PMVP has a Quick Ratio of 10.76. This indicates that PMVP is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PMVP (10.76) is better than 84.84% of its industry peers.
Industry RankSector Rank
Current Ratio 10.76
Quick Ratio 10.76
PMVP Yearly Current Assets VS Current LiabilitesPMVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for PMVP have decreased strongly by -60.00% in the last year.
EPS 1Y (TTM)-60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • PMVP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.28% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-38.24%
EPS Next 2Y-13.21%
EPS Next 3Y1.55%
EPS Next 5Y5.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMVP Yearly Revenue VS EstimatesPMVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
PMVP Yearly EPS VS EstimatesPMVP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • PMVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PMVP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMVP Price Earnings VS Forward Price EarningsPMVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMVP Per share dataPMVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.21%
EPS Next 3Y1.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PMVP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PMV PHARMACEUTICALS INC

NASDAQ:PMVP (2/25/2026, 8:00:01 PM)

After market: 1.15 +0.03 (+2.68%)

1.12

+0.06 (+5.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-04
Inst Owners60.53%
Inst Owner Change-0.06%
Ins Owners3.3%
Ins Owner Change1.66%
Market Cap59.60M
Revenue(TTM)N/A
Net Income(TTM)-82.70M
Analysts85
Price Target7.75 (591.96%)
Short Float %3.98%
Short Ratio6.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.15%
Min EPS beat(2)-4.86%
Max EPS beat(2)2.57%
EPS beat(4)2
Avg EPS beat(4)-1.81%
Min EPS beat(4)-15.92%
Max EPS beat(4)10.97%
EPS beat(8)5
Avg EPS beat(8)15.44%
EPS beat(12)9
Avg EPS beat(12)15.36%
EPS beat(16)12
Avg EPS beat(16)11.73%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.41%
EPS NY rev (1m)0%
EPS NY rev (3m)0.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-1.6
EYN/A
EPS(NY)-1.46
Fwd EYN/A
FCF(TTM)-1.37
FCFYN/A
OCF(TTM)-1.37
OCFYN/A
SpS0
BVpS2.27
TBVpS2.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.79%
ROE -68.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-28.39%
ROA(5y)-22.41%
ROE(3y)-31.23%
ROE(5y)-24.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.36%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.76
Quick Ratio 10.76
Altman-Z -2.89
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)875.85%
Cap/Depr(5y)621.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.11%
EPS Next Y-38.24%
EPS Next 2Y-13.21%
EPS Next 3Y1.55%
EPS Next 5Y5.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-18.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.04%
OCF growth 3YN/A
OCF growth 5YN/A

PMV PHARMACEUTICALS INC / PMVP FAQ

What is the fundamental rating for PMVP stock?

ChartMill assigns a fundamental rating of 2 / 10 to PMVP.


Can you provide the valuation status for PMV PHARMACEUTICALS INC?

ChartMill assigns a valuation rating of 0 / 10 to PMV PHARMACEUTICALS INC (PMVP). This can be considered as Overvalued.


How profitable is PMV PHARMACEUTICALS INC (PMVP) stock?

PMV PHARMACEUTICALS INC (PMVP) has a profitability rating of 1 / 10.


What is the earnings growth outlook for PMV PHARMACEUTICALS INC?

The Earnings per Share (EPS) of PMV PHARMACEUTICALS INC (PMVP) is expected to decline by -38.24% in the next year.